| molecular function |
|---|
| | GO:0005125 | | cytokine activity | | Functions to control the survival, growth, differentiation and effector function of tissues and cells. |
| | GO:0042802 | | identical protein binding | | Interacting selectively and non-covalently with an identical protein or proteins. |
| | GO:0002020 | | protease binding | | Interacting selectively and non-covalently with any protease or peptidase. |
| | GO:0005515 | | protein binding | | Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules). |
| | GO:0044212 | | transcription regulatory region DNA binding | | Interacting selectively and non-covalently with a DNA region that regulates the transcription of a region of DNA, which may be a gene, cistron, or operon. Binding may occur as a sequence specific interaction or as an interaction observed only once a factor has been recruited to the DNA by other factors. |
| | GO:0005164 | | tumor necrosis factor receptor binding | | Interacting selectively and non-covalently with the tumor necrosis factor receptor. |
| biological process |
|---|
| | GO:0007249 | | I-kappaB kinase/NF-kappaB signaling | | The process in which a signal is passed on to downstream components within the cell through the I-kappaB-kinase (IKK)-dependent activation of NF-kappaB. The cascade begins with activation of a trimeric IKK complex (consisting of catalytic kinase subunits IKKalpha and/or IKKbeta, and the regulatory scaffold protein NEMO) and ends with the regulation of transcription of target genes by NF-kappaB. In a resting state, NF-kappaB dimers are bound to I-kappaB proteins, sequestering NF-kappaB in the cytoplasm. Phosphorylation of I-kappaB targets I-kappaB for ubiquitination and proteasomal degradation, thus releasing the NF-kappaB dimers, which can translocate to the nucleus to bind DNA and regulate transcription. |
| | GO:0007254 | | JNK cascade | | An intracellular protein kinase cascade containing at least a JNK (a MAPK), a JNKK (a MAPKK) and a JUN3K (a MAP3K). The cascade can also contain two additional tiers: the upstream MAP4K and the downstream MAP Kinase-activated kinase (MAPKAPK). The kinases in each tier phosphorylate and activate the kinases in the downstream tier to transmit a signal within a cell. |
| | GO:0000165 | | MAPK cascade | | An intracellular protein kinase cascade containing at least a MAPK, a MAPKK and a MAP3K. The cascade can also contain two additional tiers: the upstream MAP4K and the downstream MAP Kinase-activated kinase (MAPKAPK). The kinases in each tier phosphorylate and activate the kinases in the downstream tier to transmit a signal within a cell. |
| | GO:0000187 | | activation of MAPK activity | | The initiation of the activity of the inactive enzyme MAP kinase (MAPK). |
| | GO:0000185 | | activation of MAPKKK activity | | Any process that initiates the activity of the inactive enzyme MAP kinase kinase kinase (MAPKKK). |
| | GO:0006919 | | activation of cysteine-type endopeptidase activity involved in apoptotic process | | Any process that initiates the activity of the inactive enzyme cysteine-type endopeptidase in the context of an apoptotic process. |
| | GO:0009887 | | animal organ morphogenesis | | Morphogenesis of an animal organ. An organ is defined as a tissue or set of tissues that work together to perform a specific function or functions. Morphogenesis is the process in which anatomical structures are generated and organized. Organs are commonly observed as visibly distinct structures, but may also exist as loosely associated clusters of cells that work together to perform a specific function or functions. |
| | GO:0097190 | | apoptotic signaling pathway | | A series of molecular signals which triggers the apoptotic death of a cell. The pathway starts with reception of a signal, and ends when the execution phase of apoptosis is triggered. |
| | GO:0045123 | | cellular extravasation | | The migration of a leukocyte from the blood vessels into the surrounding tissue. |
| | GO:0071230 | | cellular response to amino acid stimulus | | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an amino acid stimulus. An amino acid is a carboxylic acids containing one or more amino groups. |
| | GO:0071222 | | cellular response to lipopolysaccharide | | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a lipopolysaccharide stimulus; lipopolysaccharide is a major component of the cell wall of gram-negative bacteria. |
| | GO:0071316 | | cellular response to nicotine | | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a nicotine stimulus. |
| | GO:0071407 | | cellular response to organic cyclic compound | | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an organic cyclic compound stimulus. |
| | GO:0002439 | | chronic inflammatory response to antigenic stimulus | | A chronic inflammatory response to an antigenic stimulus. A chronic inflammatory response persists indefinitely during days, weeks, or months in the life of an individual. |
| | GO:0030866 | | cortical actin cytoskeleton organization | | A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of actin-based cytoskeletal structures in the cell cortex, i.e. just beneath the plasma membrane. |
| | GO:0071550 | | death-inducing signaling complex assembly | | A process of protein complex assembly in which the arrangement and bonding together of the set of components that form the protein complex is mediated by a death domain (DD) interaction, as part of the extrinsic apoptotic signaling pathway. |
| | GO:0006952 | | defense response | | Reactions, triggered in response to the presence of a foreign body or the occurrence of an injury, which result in restriction of damage to the organism attacked or prevention/recovery from the infection caused by the attack. |
| | GO:0050830 | | defense response to Gram-positive bacterium | | Reactions triggered in response to the presence of a Gram-positive bacterium that act to protect the cell or organism. |
| | GO:0042742 | | defense response to bacterium | | Reactions triggered in response to the presence of a bacterium that act to protect the cell or organism. |
| | GO:0048566 | | embryonic digestive tract development | | The process whose specific outcome is the progression of the gut over time, from its formation to the mature structure during embryonic development. The gut is the region of the digestive tract extending from the beginning of the intestines to the anus. |
| | GO:0060664 | | epithelial cell proliferation involved in salivary gland morphogenesis | | The multiplication or reproduction of epithelial cells of the submandibular salivary gland, resulting in the expansion of a cell population and the shaping of the gland. |
| | GO:0090002 | | establishment of protein localization to plasma membrane | | The directed movement of a protein to a specific location in the plasma membrane. |
| | GO:0030198 | | extracellular matrix organization | | A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of an extracellular matrix. |
| | GO:0097191 | | extrinsic apoptotic signaling pathway | | A series of molecular signals in which a signal is conveyed from the cell surface to trigger the apoptotic death of a cell. The pathway starts with either a ligand binding to a cell surface receptor, or a ligand being withdrawn from a cell surface receptor (e.g. in the case of signaling by dependence receptors), and ends when the execution phase of apoptosis is triggered. |
| | GO:0008625 | | extrinsic apoptotic signaling pathway via death domain receptors | | A series of molecular signals in which a signal is conveyed from the cell surface to trigger the apoptotic death of a cell. The pathway starts with a ligand binding to a death domain receptor on the cell surface, and ends when the execution phase of apoptosis is triggered. |
| | GO:0006006 | | glucose metabolic process | | The chemical reactions and pathways involving glucose, the aldohexose gluco-hexose. D-glucose is dextrorotatory and is sometimes known as dextrose; it is an important source of energy for living organisms and is found free as well as combined in homo- and hetero-oligosaccharides and polysaccharides. |
| | GO:0006959 | | humoral immune response | | An immune response mediated through a body fluid. |
| | GO:0006955 | | immune response | | Any immune system process that functions in the calibrated response of an organism to a potential internal or invasive threat. |
| | GO:0006954 | | inflammatory response | | The immediate defensive reaction (by vertebrate tissue) to infection or injury caused by chemical or physical agents. The process is characterized by local vasodilation, extravasation of plasma into intercellular spaces and accumulation of white blood cells and macrophages. |
| | GO:0008630 | | intrinsic apoptotic signaling pathway in response to DNA damage | | A series of molecular signals in which an intracellular signal is conveyed to trigger the apoptotic death of a cell. The pathway is induced by the detection of DNA damage, and ends when the execution phase of apoptosis is triggered. |
| | GO:0050900 | | leukocyte migration | | The movement of a leukocyte within or between different tissues and organs of the body. |
| | GO:0050901 | | leukocyte tethering or rolling | | Transient adhesive interactions between leukocytes and endothelial cells lining blood vessels. Carbohydrates on circulating leukocytes bind selectins on the vessel wall causing the leukocytes to slow down and roll along the inner surface of the vessel wall. During this rolling motion, transitory bonds are formed and broken between selectins and their ligands. Typically the first step in cellular extravasation (the movement of leukocytes out of the circulatory system, towards the site of tissue damage or infection). |
| | GO:0031663 | | lipopolysaccharide-mediated signaling pathway | | A series of molecular signals initiated by the binding of a lipopolysaccharide (LPS) to a receptor on the surface of a target cell, and ending with regulation of a downstream cellular process, e.g. transcription. Lipopolysaccharides are major components of the outer membrane of Gram-negative bacteria, making them prime targets for recognition by the immune system. |
| | GO:0007275 | | multicellular organism development | | The biological process whose specific outcome is the progression of a multicellular organism over time from an initial condition (e.g. a zygote or a young adult) to a later condition (e.g. a multicellular animal or an aged adult). |
| | GO:0097527 | | necroptotic signaling pathway | | A series of molecular signals which triggers the necroptotic death of a cell. The pathway starts with reception of a signal, is characterized by activation of receptor-interacting serine/threonine-protein kinase 1 and/or 3 (RIPK1/3, also called RIP1/3), and ends when the execution phase of necroptosis is triggered. |
| | GO:0010693 | | negative regulation of alkaline phosphatase activity | | Any process that decreases the frequency, rate or extent of alkaline phosphatase activity, the catalysis of the reaction: an orthophosphoric monoester + H2O = an alcohol + phosphate, with an alkaline pH optimum. |
| | GO:1903347 | | negative regulation of bicellular tight junction assembly | | Any process that stops, prevents or reduces the frequency, rate or extent of tight junction assembly. |
| | GO:0061048 | | negative regulation of branching involved in lung morphogenesis | | Any process that decreases the rate, frequency, or extent of the process in which a highly ordered sequence of patterning events generates the branched structures of the lung, consisting of reiterated combinations of bud outgrowth, elongation, and dichotomous subdivision of terminal units. |
| | GO:0002740 | | negative regulation of cytokine secretion involved in immune response | | Any process that stops, prevents, or reduces the frequency, rate, or extent of cytokine secretion contributing to an immune response. |
| | GO:2001240 | | negative regulation of extrinsic apoptotic signaling pathway in absence of ligand | | Any process that stops, prevents or reduces the frequency, rate or extent of extrinsic apoptotic signaling pathway in absence of ligand. |
| | GO:0045599 | | negative regulation of fat cell differentiation | | Any process that stops, prevents, or reduces the frequency, rate or extent of adipocyte differentiation. |
| | GO:0010629 | | negative regulation of gene expression | | Any process that decreases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA or circRNA (for protein-coding genes) and the translation of that mRNA or circRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form. |
| | GO:0046325 | | negative regulation of glucose import | | Any process that stops, prevents, or reduces the frequency, rate or extent of the import of the hexose monosaccharide glucose into a cell or organelle. |
| | GO:0044130 | | negative regulation of growth of symbiont in host | | Any process in which the symbiont stops, prevents or reduces its increase in size or mass within the cells or tissues of the host organism. The host is defined as the larger of the organisms involved in the symbiotic interaction. |
| | GO:0032715 | | negative regulation of interleukin-6 production | | Any process that stops, prevents, or reduces the frequency, rate, or extent of interleukin-6 production. |
| | GO:0050995 | | negative regulation of lipid catabolic process | | Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways resulting in the breakdown of lipids. |
| | GO:0010888 | | negative regulation of lipid storage | | Any process that decreases the rate, frequency or extent of lipid storage. Lipid storage is the accumulation and maintenance in cells or tissues of lipids, compounds soluble in organic solvents but insoluble or sparingly soluble in aqueous solvents. Lipid reserves can be accumulated during early developmental stages for mobilization and utilization at later stages of development. |
| | GO:0045662 | | negative regulation of myoblast differentiation | | Any process that stops, prevents, or reduces the frequency, rate or extent of myoblast differentiation. A myoblast is a mononucleate cell type that, by fusion with other myoblasts, gives rise to the myotubes that eventually develop into skeletal muscle fibers. |
| | GO:0035509 | | negative regulation of myosin-light-chain-phosphatase activity | | Any process that stops, prevents, or reduces the frequency, rate or extent of myosin-light-chain-phosphatase activity. |
| | GO:0045668 | | negative regulation of osteoblast differentiation | | Any process that stops, prevents, or reduces the frequency, rate or extent of osteoblast differentiation. |
| | GO:0043242 | | negative regulation of protein complex disassembly | | Any process that stops, prevents, or reduces the frequency, rate or extent of protein complex disassembly, the disaggregation of a protein complex into its constituent components. |
| | GO:0000122 | | negative regulation of transcription from RNA polymerase II promoter | | Any process that stops, prevents, or reduces the frequency, rate or extent of transcription from an RNA polymerase II promoter. |
| | GO:0045892 | | negative regulation of transcription, DNA-templated | | Any process that stops, prevents, or reduces the frequency, rate or extent of cellular DNA-templated transcription. |
| | GO:0045071 | | negative regulation of viral genome replication | | Any process that stops, prevents, or reduces the frequency, rate or extent of viral genome replication. |
| | GO:0006927 | | obsolete transformed cell apoptotic process | | OBSOLETE. Any apoptotic process in a transformed cell, a cell that has undergone changes manifested by escape from control mechanisms, increased growth potential, alterations in the cell surface, karyotypic abnormalities, morphological and biochemical deviations from the norm. |
| | GO:0030316 | | osteoclast differentiation | | The process in which a relatively unspecialized monocyte acquires the specialized features of an osteoclast. An osteoclast is a specialized phagocytic cell associated with the absorption and removal of the mineralized matrix of bone tissue. |
| | GO:0070374 | | positive regulation of ERK1 and ERK2 cascade | | Any process that activates or increases the frequency, rate or extent of signal transduction mediated by the ERK1 and ERK2 cascade. |
| | GO:0043123 | | positive regulation of I-kappaB kinase/NF-kappaB signaling | | Any process that activates or increases the frequency, rate or extent of I-kappaB kinase/NF-kappaB signaling. |
| | GO:0046330 | | positive regulation of JNK cascade | | Any process that activates or increases the frequency, rate or extent of signal transduction mediated by the JNK cascade. |
| | GO:0043507 | | positive regulation of JUN kinase activity | | Any process that activates or increases the frequency, rate or extent of JUN kinase activity. |
| | GO:0043406 | | positive regulation of MAP kinase activity | | Any process that activates or increases the frequency, rate or extent of MAP kinase activity. |
| | GO:0042346 | | positive regulation of NF-kappaB import into nucleus | | Any process that activates or increases the frequency, rate or extent of transfer of NF-kappaB, a transcription factor for eukaryotic RNA polymerase II promoters, from the cytoplasm into the nucleus, across the nuclear membrane. |
| | GO:0051092 | | positive regulation of NF-kappaB transcription factor activity | | Any process that activates or increases the frequency, rate or extent of activity of the transcription factor NF-kappaB. |
| | GO:0051533 | | positive regulation of NFAT protein import into nucleus | | Any process that activates or increases the frequency, rate or extent of the movement of an NFAT protein from the cytoplasm to the nucleus. |
| | GO:1901224 | | positive regulation of NIK/NF-kappaB signaling | | Any process that activates or increases the frequency, rate or extent of NIK/NF-kappaB signaling. |
| | GO:0043065 | | positive regulation of apoptotic process | | Any process that activates or increases the frequency, rate or extent of cell death by apoptotic process. |
| | GO:2000334 | | positive regulation of blood microparticle formation | | Any process that activates or increases the frequency, rate or extent of blood microparticle formation. |
| | GO:0060559 | | positive regulation of calcidiol 1-monooxygenase activity | | Any process that increases the rate, frequency or extent of calcidiol 1-monooxygenase activity. Calcidiol 1-monooxygenase activity is the catalysis of the reaction: calcidiol + NADPH + H+ + O2 = calcitriol + NADP+ + H2O. |
| | GO:0045785 | | positive regulation of cell adhesion | | Any process that activates or increases the frequency, rate or extent of cell adhesion. |
| | GO:2000304 | | positive regulation of ceramide biosynthetic process | | Any process that activates or increases the frequency, rate or extent of ceramide biosynthetic process. |
| | GO:2000343 | | positive regulation of chemokine (C-X-C motif) ligand 2 production | | Any process that activates or increases the frequency, rate or extent of chemokine (C-X-C motif) ligand 2 production. |
| | GO:0045080 | | positive regulation of chemokine biosynthetic process | | Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of chemokines. |
| | GO:0032722 | | positive regulation of chemokine production | | Any process that activates or increases the frequency, rate, or extent of chemokine production. |
| | GO:0002876 | | positive regulation of chronic inflammatory response to antigenic stimulus | | Any process that activates or increases the frequency, rate, or extent of a chronic inflammatory response to an antigenic stimulus. |
| | GO:0043280 | | positive regulation of cysteine-type endopeptidase activity involved in apoptotic process | | Any process that activates or increases the activity of a cysteine-type endopeptidase involved in the apoptotic process. |
| | GO:0001819 | | positive regulation of cytokine production | | Any process that activates or increases the frequency, rate or extent of production of a cytokine. |
| | GO:0050715 | | positive regulation of cytokine secretion | | Any process that activates or increases the frequency, rate or extent of the regulated release of cytokines from a cell. |
| | GO:0031622 | | positive regulation of fever generation | | Any process that activates or increases the frequency, rate, or extent of fever generation. |
| | GO:0010628 | | positive regulation of gene expression | | Any process that increases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA or circRNA (for protein-coding genes) and the translation of that mRNA or circRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form. |
| | GO:0051798 | | positive regulation of hair follicle development | | Any process that activates or increases the frequency, rate or extent of hair follicle development. |
| | GO:0034116 | | positive regulation of heterotypic cell-cell adhesion | | Any process that activates or increases the frequency, rate, or extent of heterotypic cell-cell adhesion. |
| | GO:0002925 | | positive regulation of humoral immune response mediated by circulating immunoglobulin | | Any process that activates or increases the frequency, rate, or extent of a humoral immune response mediated by circulating immunoglobulin. |
| | GO:0032729 | | positive regulation of interferon-gamma production | | Any process that activates or increases the frequency, rate, or extent of interferon-gamma production. Interferon-gamma is also known as type II interferon. |
| | GO:0032755 | | positive regulation of interleukin-6 production | | Any process that activates or increases the frequency, rate, or extent of interleukin-6 production. |
| | GO:0045416 | | positive regulation of interleukin-8 biosynthetic process | | Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of interleukin-8. |
| | GO:0032757 | | positive regulation of interleukin-8 production | | Any process that activates or increases the frequency, rate, or extent of interleukin-8 production. |
| | GO:1904999 | | positive regulation of leukocyte adhesion to arterial endothelial cell | | Any process that activates or increases the frequency, rate or extent of leukocyte adhesion to arterial endothelial cell. |
| | GO:0051044 | | positive regulation of membrane protein ectodomain proteolysis | | Any process that activates or increases the frequency, rate or extent of membrane protein ectodomain peptidolysis. |
| | GO:0071677 | | positive regulation of mononuclear cell migration | | Any process that increases the rate, frequency or extent of mononuclear cell migration. Mononuclear cell migration is the movement of a mononuclear cell within or between different tissues and organs of the body. |
| | GO:0045429 | | positive regulation of nitric oxide biosynthetic process | | Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of nitric oxide. |
| | GO:0045672 | | positive regulation of osteoclast differentiation | | Any process that activates or increases the frequency, rate or extent of osteoclast differentiation. |
| | GO:0033138 | | positive regulation of peptidyl-serine phosphorylation | | Any process that activates or increases the frequency, rate or extent of the phosphorylation of peptidyl-serine. |
| | GO:0050766 | | positive regulation of phagocytosis | | Any process that activates or increases the frequency, rate or extent of phagocytosis. |
| | GO:0071803 | | positive regulation of podosome assembly | | Any process that activates or increases the rate or extent of podosome assembly. |
| | GO:0043068 | | positive regulation of programmed cell death | | Any process that activates or increases the frequency, rate or extent of programmed cell death, cell death resulting from activation of endogenous cellular processes. |
| | GO:0031334 | | positive regulation of protein complex assembly | | Any process that activates or increases the frequency, rate or extent of protein complex assembly. |
| | GO:0043243 | | positive regulation of protein complex disassembly | | Any process that activates or increases the frequency, rate or extent of protein complex disassembly, the disaggregation of a protein complex into its constituent components. |
| | GO:0051897 | | positive regulation of protein kinase B signaling | | Any process that activates or increases the frequency, rate or extent of protein kinase B signaling, a series of reactions mediated by the intracellular serine/threonine kinase protein kinase B. |
| | GO:0045860 | | positive regulation of protein kinase activity | | Any process that activates or increases the frequency, rate or extent of protein kinase activity. |
| | GO:2000010 | | positive regulation of protein localization to cell surface | | Any process that activates or increases the frequency, rate or extent of protein localization to the cell surface. |
| | GO:0001934 | | positive regulation of protein phosphorylation | | Any process that activates or increases the frequency, rate or extent of addition of phosphate groups to amino acids within a protein. |
| | GO:0051222 | | positive regulation of protein transport | | Any process that activates or increases the frequency, rate or extent of the directed movement of a protein into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore. |
| | GO:0051091 | | positive regulation of sequence-specific DNA binding transcription factor activity | | Any process that activates or increases the frequency, rate or extent of activity of a transcription factor, any factor involved in the initiation or regulation of transcription. |
| | GO:0048661 | | positive regulation of smooth muscle cell proliferation | | Any process that activates or increases the rate or extent of smooth muscle cell proliferation. |
| | GO:1901671 | | positive regulation of superoxide dismutase activity | | Any process that activates or increases the frequency, rate or extent of superoxide dismutase activity. |
| | GO:0045944 | | positive regulation of transcription from RNA polymerase II promoter | | Any process that activates or increases the frequency, rate or extent of transcription from an RNA polymerase II promoter. |
| | GO:0045893 | | positive regulation of transcription, DNA-templated | | Any process that activates or increases the frequency, rate or extent of cellular DNA-templated transcription. |
| | GO:0045994 | | positive regulation of translational initiation by iron | | Any process involving iron that activates or increases the rate of translational initiation. |
| | GO:0060557 | | positive regulation of vitamin D biosynthetic process | | Any process that increases the rate, frequency or extent of a vitamin D biosynthetic process. Vitamin D biosynthesis is the chemical reactions and pathways resulting in the formation of vitamin D, any of a group of related, fat-soluble compounds that are derived from delta-5,7 steroids and play a central role in calcium metabolism. Specific forms of vitamin D include calciferol (ergocalciferol; vitamin D2) and cholecalciferol (calciol; vitamin D3). |
| | GO:0000060 | | protein import into nucleus, translocation | | A protein transport process that contributes to protein import into the nucleus, and that results in the vectorial transfer of a cargo-carrier protein complex through the nuclear pore complex from the cytoplasmic side to the nucleoplasmic side of the nuclear envelope. |
| | GO:0043491 | | protein kinase B signaling | | A series of reactions, mediated by the intracellular serine/threonine kinase protein kinase B (also called AKT), which occurs as a result of a single trigger reaction or compound. |
| | GO:0032800 | | receptor biosynthetic process | | The chemical reactions and pathways resulting in the formation of a receptor molecule, a macromolecule that undergoes combination with a hormone, neurotransmitter, drug or intracellular messenger to initiate a change in cell function. |
| | GO:0043122 | | regulation of I-kappaB kinase/NF-kappaB signaling | | Any process that modulates I-kappaB kinase/NF-kappaB signaling. |
| | GO:0060693 | | regulation of branching involved in salivary gland morphogenesis | | Any process that modulates the rate, frequency, or extent of branching morphogenesis in the salivary gland epithelium. |
| | GO:0042127 | | regulation of cell proliferation | | Any process that modulates the frequency, rate or extent of cell proliferation. |
| | GO:1903140 | | regulation of establishment of endothelial barrier | | Any process that modulates the frequency, rate or extent of establishment of endothelial barrier. |
| | GO:0051023 | | regulation of immunoglobulin secretion | | Any process that modulates the frequency, rate or extent of the regulated release of immunoglobulins from a cell. |
| | GO:0050796 | | regulation of insulin secretion | | Any process that modulates the frequency, rate or extent of the regulated release of insulin. |
| | GO:0045670 | | regulation of osteoclast differentiation | | Any process that modulates the frequency, rate or extent of osteoclast differentiation. |
| | GO:0001932 | | regulation of protein phosphorylation | | Any process that modulates the frequency, rate or extent of addition of phosphate groups into an amino acid in a protein. |
| | GO:0050708 | | regulation of protein secretion | | Any process that modulates the frequency, rate or extent of the controlled release of a protein from a cell. |
| | GO:2000377 | | regulation of reactive oxygen species metabolic process | | Any process that modulates the frequency, rate or extent of reactive oxygen species metabolic process. |
| | GO:0010803 | | regulation of tumor necrosis factor-mediated signaling pathway | | Any process that modulates the rate or extent of the tumor necrosis factor-mediated signaling pathway. The tumor necrosis factor-mediated signaling pathway is the series of molecular signals generated as a consequence of tumor necrosis factor binding to a cell surface receptor. |
| | GO:0051384 | | response to glucocorticoid | | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a glucocorticoid stimulus. Glucocorticoids are hormonal C21 corticosteroids synthesized from cholesterol with the ability to bind with the cortisol receptor and trigger similar effects. Glucocorticoids act primarily on carbohydrate and protein metabolism, and have anti-inflammatory effects. |
| | GO:0010033 | | response to organic substance | | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an organic substance stimulus. |
| | GO:0009651 | | response to salt stress | | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating an increase or decrease in the concentration of salt (particularly but not exclusively sodium and chloride ions) in the environment. |
| | GO:0009615 | | response to virus | | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus from a virus. |
| | GO:0030730 | | sequestering of triglyceride | | The process of binding or confining any triester of glycerol such that it is separated from other components of a biological system. |
| | GO:0033209 | | tumor necrosis factor-mediated signaling pathway | | A series of molecular signals initiated by the binding of a tumor necrosis factor to a receptor on the surface of a cell, and ending with regulation of a downstream cellular process, e.g. transcription. |
| cellular component |
|---|
| | GO:0009986 | | cell surface | | The external part of the cell wall and/or plasma membrane. |
| | GO:0009897 | | external side of plasma membrane | | The leaflet of the plasma membrane that faces away from the cytoplasm and any proteins embedded or anchored in it or attached to its surface. |
| | GO:0005576 | | extracellular region | | The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite. |
| | GO:0005615 | | extracellular space | | That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid. |
| | GO:0016021 | | integral component of membrane | | The component of a membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane. |
| | GO:0005887 | | integral component of plasma membrane | | The component of the plasma membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane. |
| | GO:0005622 | | intracellular | | The living contents of a cell; the matter contained within (but not including) the plasma membrane, usually taken to exclude large vacuoles and masses of secretory or ingested material. In eukaryotes it includes the nucleus and cytoplasm. |
| | GO:0016020 | | membrane | | A lipid bilayer along with all the proteins and protein complexes embedded in it an attached to it. |
| | GO:0045121 | | membrane raft | | Any of the small (10-200 nm), heterogeneous, highly dynamic, sterol- and sphingolipid-enriched membrane domains that compartmentalize cellular processes. Small rafts can sometimes be stabilized to form larger platforms through protein-protein and protein-lipid interactions. |
| | GO:0001891 | | phagocytic cup | | An invagination of the cell membrane formed by an actin dependent process during phagocytosis. Following internalization it is converted into a phagosome. |
| | GO:0005886 | | plasma membrane | | The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins. |
| | GO:0055037 | | recycling endosome | | An organelle consisting of a network of tubules that functions in targeting molecules, such as receptors transporters and lipids, to the plasma membrane. |
Description
